Picture of Diaceutics logo

DXRX Diaceutics News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsAdventurousSmall CapHigh Flyer

REG - AIM - AIM Notice - 26/01/2024

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240126:nRSZ9615Aa&default-theme=true

RNS Number : 9615A  AIM  26 January 2024

NOTICE

 

26/01/2024 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 CREO MEDICAL GROUP PLC
 225,024  ORDINARY SHARES OF GBP0.001 EACH FULLY PAID  (BZ1BLL4)(GB00BZ1BLL44)

 

 DIACEUTICS PLC
 177,915  ORDINARY SHARES OF GBP0.002 EACH, FULLY PAID  (BJQTGV6)(GB00BJQTGV64)

 

 DX (GROUP) PLC
 42,298,644  ORDINARY SHARES OF 1P EACH, FULLY PAID  (BJTCG67)(GB00BJTCG679)

 

 EMPIRE METALS LIMITED
 27,272,728  ORDINARY SHARES OF NO PAR VALUE, FULLY PAID, (DI)  (BKTZQR4)(VGG3036T1012)

 

 INSPIRED PLC
 115,000  ORDINARY SHARES OF 1.25P EACH FULLY PAID  (BR2Q0V5)(GB00BR2Q0V58)

 

 MOLECULAR ENERGIES PLC
 1,852,824  ORDINARY SHARES OF 1P EACH, FULLY PAID  (BMT80K8)(GB00BMT80K89)

 

 ORIOLE RESOURCES PLC
 17,444,445  ORDINARY SHARES OF 0.1P EACH, FULLY PAID  (B0T2932)(GB00B0T29327)

 

 SOLID STATE PLC
 26,750  ORDINARY SHARES OF 5P EACH, FULLY PAID  (0823713)(GB0008237132)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOBUGDBUUDDGSU

Recent news on Diaceutics

See all news